109 related articles for article (PubMed ID: 15838263)
1. Endothelin-B receptor blockade inhibits molecular effectors of melanoma cell progression.
Rosanò L; Spinella F; Genovesi G; Di Castro V; Natali PG; Bagnato A
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S136-9. PubMed ID: 15838263
[TBL] [Abstract][Full Text] [Related]
2. Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression.
Bagnato A; Rosanò L; Spinella F; Di Castro V; Tecce R; Natali PG
Cancer Res; 2004 Feb; 64(4):1436-43. PubMed ID: 14973117
[TBL] [Abstract][Full Text] [Related]
3. Targeting the endothelin axis in human melanoma: combination of endothelin receptor antagonism and alkylating agents.
Berger Y; Bernasconi CC; Juillerat-Jeanneret L
Exp Biol Med (Maywood); 2006 Jun; 231(6):1111-9. PubMed ID: 16741059
[TBL] [Abstract][Full Text] [Related]
4. α-Catulin downregulates E-cadherin and promotes melanoma progression and invasion.
Kreiseder B; Orel L; Bujnow C; Buschek S; Pflueger M; Schuett W; Hundsberger H; de Martin R; Wiesner C
Int J Cancer; 2013 Feb; 132(3):521-30. PubMed ID: 22733455
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
6. UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells.
Jamal S; Schneider RJ
J Clin Invest; 2002 Aug; 110(4):443-52. PubMed ID: 12189238
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1 upregulates MCAM in melanocytes.
Mangahas CR; dela Cruz GV; Schneider RJ; Jamal S
J Invest Dermatol; 2004 Dec; 123(6):1135-9. PubMed ID: 15610525
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
[TBL] [Abstract][Full Text] [Related]
9. An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo.
Lahav R; Heffner G; Patterson PH
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11496-500. PubMed ID: 10500205
[TBL] [Abstract][Full Text] [Related]
10. The endothelin/sarafotoxin-induced increase of the proliferation of undifferentiated and DMSO-differentiated GEM-81 goldfish erythrophoroma cells is mediated by ETB receptors.
Filadelfi AM; Ramanzini GC; Visconti MA; Castrucci AM
Pigment Cell Res; 2004 Oct; 17(5):480-7. PubMed ID: 15357834
[TBL] [Abstract][Full Text] [Related]
11. Functional endothelin ET B receptors are selectively expressed in human oligodendrogliomas.
Anguelova E; Beuvon F; Leonard N; Chaverot N; Varlet P; Couraud PO; Daumas-Duport C; Cazaubon S
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):77-88. PubMed ID: 15950764
[TBL] [Abstract][Full Text] [Related]
12. Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Albini A; Natali PG; Bagnato A
Am J Pathol; 2003 Aug; 163(2):753-62. PubMed ID: 12875994
[TBL] [Abstract][Full Text] [Related]
13. Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway.
Qi J; Chen N; Wang J; Siu CH
Mol Biol Cell; 2005 Sep; 16(9):4386-97. PubMed ID: 15987741
[TBL] [Abstract][Full Text] [Related]
14. Endothelin receptor B is required for the expansion of melanocyte precursors and malignant melanoma.
Lahav R
Int J Dev Biol; 2005; 49(2-3):173-80. PubMed ID: 15906230
[TBL] [Abstract][Full Text] [Related]
15. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
[TBL] [Abstract][Full Text] [Related]
16. Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail.
Hao L; Ha JR; Kuzel P; Garcia E; Persad S
Br J Dermatol; 2012 Jun; 166(6):1184-97. PubMed ID: 22332917
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
18. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
[TBL] [Abstract][Full Text] [Related]
19. Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas.
Lahav R; Suvà ML; Rimoldi D; Patterson PH; Stamenkovic I
Cancer Res; 2004 Dec; 64(24):8945-53. PubMed ID: 15604257
[TBL] [Abstract][Full Text] [Related]
20. Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor.
Montgomery JP; Patterson PH
BMC Cancer; 2008 Nov; 8():354. PubMed ID: 19040731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
